Literature DB >> 12859955

Induction of apoptosis by depletion of DNA topoisomerase IIalpha in mammalian cells.

Nobuyoshi Akimitsu1, Koushirou Kamura, Shigenobu Toné, Ayako Sakaguchi, Akihiko Kikuchi, Hiroshi Hamamoto, Kazuhisa Sekimizu.   

Abstract

Inactivation of topoisomerase (topo) IIalpha arrests murine embryonic development. In topo IIalpha-depleted embryos, nuclei were partitioned to daughter cells without complete separation and formed an interconnecting droplet-like structure. The present study examined the fates of topo IIalpha-depleted cells with the droplet-like nuclear structure. When the embryos with abnormal nuclei were further incubated, apoptosis was induced along with the formation of fragmented and terminal deoxynucleotidyl transferase-mediated dUTP nick end labeling positive nuclei. ICRF-193 treatment of embryos activated caspases. Apoptosis induced by ICRF-193 was suppressed by z-VAD-fmk, a caspase inhibitor, and pifithrin-alpha, a p53 inhibitor. Moreover, when mitosis was blocked by nocodazole, ICRF-193-induced nuclear abnormalities and apoptosis were abolished. These data suggest that cycling through the M-phase is essential for ICRF-193-induced apoptosis. Nuclear abnormalities similar to those of topo IIalpha-depleted embryos were induced in HeLa cells in which topo IIalpha was knocked down by transfection with short interfering RNA (siRNA) against topo IIalpha, followed by induction of apoptosis. Our results suggest that topo IIalpha-depleted cells with the droplet-like nuclear structure induce apoptosis, which is dependent on caspase and p53 activity during the G1 phase in mammalian cells.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12859955     DOI: 10.1016/s0006-291x(03)01169-0

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  12 in total

1.  Protein kinase C delta activates topoisomerase IIalpha to induce apoptotic cell death in response to DNA damage.

Authors:  Kiyotsugu Yoshida; Tomoko Yamaguchi; Hirokuni Shinagawa; Naoe Taira; Keiichi I Nakayama; Yoshio Miki
Journal:  Mol Cell Biol       Date:  2006-05       Impact factor: 4.272

2.  Efficacy of substituted 9-aminoacridine derivatives in small cell lung cancer.

Authors:  Etchison Ryan; A Jacobson Blake; A Benoit; M Ferguson David; A Kratzke Robert
Journal:  Invest New Drugs       Date:  2012-07-22       Impact factor: 3.850

3.  Novel acridine-based agents with topoisomerase II inhibitor activity suppress mesothelioma cell proliferation and induce apoptosis.

Authors:  Ahmad Raza; Blake A Jacobson; Adam Benoit; Manish R Patel; Joe Jay-Dixon; Hiroshi Hiasa; David M Ferguson; Robert Arthur Kratzke
Journal:  Invest New Drugs       Date:  2011-07-26       Impact factor: 3.850

4.  Anti-proliferative effects of simocyclinone D8 (SD8), a novel catalytic inhibitor of topoisomerase II.

Authors:  Ahad A Sadiq; Manish R Patel; Blake A Jacobson; Marco Escobedo; Keith Ellis; Lisa M Oppegard; Hiroshi Hiasa; Robert A Kratzke
Journal:  Invest New Drugs       Date:  2009-01-10       Impact factor: 3.850

5.  RECQL5 cooperates with Topoisomerase II alpha in DNA decatenation and cell cycle progression.

Authors:  Mahesh Ramamoorthy; Takashi Tadokoro; Ivana Rybanska; Avik K Ghosh; Robert Wersto; Alfred May; Tomasz Kulikowicz; Peter Sykora; Deborah L Croteau; Vilhelm A Bohr
Journal:  Nucleic Acids Res       Date:  2011-10-19       Impact factor: 16.971

6.  Identification of genes involved in Ca2+ ionophore A23187-mediated apoptosis and demonstration of a high susceptibility for transcriptional repression of cell cycle genes in B lymphoblasts from a patient with Scott syndrome.

Authors:  Detlef Kozian; Valérie Proulle; Almut Nitsche; Marie Galitzine; Marie-Carmen Martinez; Beatrice Schumann; Dominique Meyer; Matthias Herrmann; Jean-Marie Freyssinet; Danièle Kerbiriou-Nabias
Journal:  BMC Genomics       Date:  2005-10-21       Impact factor: 3.969

7.  c-erbB2 and topoisomerase IIalpha protein expression independently predict poor survival in primary human breast cancer: a retrospective study.

Authors:  Peter Fritz; Cristina M Cabrera; Jürgen Dippon; Andreas Gerteis; Wolfgang Simon; Walter E Aulitzky; Heiko van der Kuip
Journal:  Breast Cancer Res       Date:  2005-03-21       Impact factor: 6.466

Review 8.  Topoisomerase II: a fitted mechanism for the chromatin landscape.

Authors:  Joaquim Roca
Journal:  Nucleic Acids Res       Date:  2008-12-05       Impact factor: 16.971

9.  Expression of human MCM6 and DNA Topo II alpha in craniopharyngiomas and its correlation with recurrence of the tumor.

Authors:  Jianguo Xu; Sizhong Zhang; Chao You; Siqing Huang; Bowen Cai; Xiaojie Wang
Journal:  J Neurooncol       Date:  2007-04-05       Impact factor: 4.506

10.  Genome-wide ChIP-seq analysis of human TOP2B occupancy in MCF7 breast cancer epithelial cells.

Authors:  Catriona M Manville; Kayleigh Smith; Zbyslaw Sondka; Holly Rance; Simon Cockell; Ian G Cowell; Ka Cheong Lee; Nicholas J Morris; Kay Padget; Graham H Jackson; Caroline A Austin
Journal:  Biol Open       Date:  2015-10-12       Impact factor: 2.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.